多血症治療薬の世界市場:市場インサイト、疫学、市場予測

◆英語タイトル:Polycythemia-Market Insights, Epidemiology and Market Forecast-2023
◆商品コード:DLVEP06157
◆発行会社(調査会社):DelveInsight
◆発行日:2016年8月
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後10営業日)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD4,950 ⇒換算¥549,450見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD9,900 ⇒換算¥1,098,900見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD14,850 ⇒換算¥1,648,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規販売代理店です。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、多血症治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。
・多血症の概要
・病態生理
・多血症の症状
・多血症の病因
・多血症の診断
・多血症の治療
・上市品の概要
・医薬品の説明
・作用機序
・薬物動態学的特性
・特許情報
・多血症の疫学分析
・多血症治療薬の世界市場規模
・多血症治療薬の世界市場予測
・多血症治療薬のアメリカ市場規模
・多血症治療薬のアメリカ市場予測
・多血症治療薬のヨーロッパ市場規模
・多血症治療薬のヨーロッパ市場予測
(ドイツ、イギリス、フランス、イタリア、スペイン)
・多血症治療薬の日本市場規模
・多血症治療薬の日本市場予測
【レポートの概要】

Note*: This report requires 7-10 business days to complete.

DelveInsight’s Polycythemia – Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Polycythemia for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Polycythemia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Polycythemia till 2023.

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Polycythemia market.
• Identifying patient populations in the global “Polycythemia market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Polycythemia therapeutics in each of the markets covered.
• To understand the future market competition in the global Polycythemia therapeutics market and Insightful review of the key market drivers and barriers.

Scope

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Polycythemia for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

【レポートの目次】

Table of Contents

• Polycythemia overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Polycythemia Market
• Global Epidemiology of Polycythemia Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight

List of Tables

• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Polycythemia Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Polycythemia (2013-2023)
• Table 7: Polycythemia Global Market (USD Millions), (2013-2015)
• Table 8: Polycythemia Global Market (USD Millions), (2016-2023)
• Table 9: Polycythemia US Market (USD Millions), (2013-2015)
• Table 10: Polycythemia US Market (USD Millions), (2016-2023)
• Table 11: Polycythemia Germany Market (USD Millions), (2013-2015)
• Table 12: Polycythemia Germany Market (USD Millions), (2016-2023)
• Table 13: Polycythemia United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Polycythemia United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Polycythemia France Market (USD Millions), (2013-2015)
• Table 16: Polycythemia France Market (USD Millions), (2016-2023)
• Table 17: Polycythemia Italy Market (USD Millions), (2013-2015)
• Table 18: Polycythemia Italy Market (USD Millions), (2016-2023)
• Table 19: Polycythemia Spain Market (USD Millions), (2013-2015)
• Table 20: Polycythemia Spain Market (USD Millions), (2016-2023)
• Table 21: Polycythemia Japan Market (USD Millions), (2013-2015)
• Table 22: Polycythemia Japan Market (USD Millions), (2016-2023)
• Table 23: Polycythemia ROW Market (USD Millions), (2013-2015)
• Table 24: Polycythemia ROW Market (USD Millions), (2016-2023)

List of Figures

• Figure 1: Polycythemia Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Polycythemia (2013-2023)
• Figure 3: Polycythemia Global Market (USD Millions), (2013-2015)
• Figure 4: Polycythemia Global Market (USD Millions), (2016-2023)
• Figure 5: Polycythemia US Market (USD Millions), (2013-2015)
• Figure 6: Polycythemia US Market (USD Millions), (2016-2023)
• Figure 7: Polycythemia Germany Market (USD Millions), (2013-2015)
• Figure 8: Polycythemia Germany Market (USD Millions), (2016-2023)
• Figure 9: Polycythemia United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Polycythemia United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Polycythemia France Market (USD Millions), (2013-2015)
• Figure 12: Polycythemia France Market (USD Millions), (2016-2023)
• Figure 13: Polycythemia Italy Market (USD Millions), (2013-2015)
• Figure 14: Polycythemia Italy Market (USD Millions), (2016-2023)
• Figure 15: Polycythemia Spain Market (USD Millions), (2013-2015)
• Figure 16: Polycythemia Spain Market (USD Millions), (2016-2023)
• Figure 17: Polycythemia Japan Market (USD Millions), (2013-2015)
• Figure 18: Polycythemia Japan Market (USD Millions), (2015-2023)
• Figure 19: Polycythemia ROW Market (USD Millions), (2013-2015)
• Figure 20: Polycythemia ROW Market (USD Millions), (2016-2023)



【掲載企業】

• Bristol-Myers Squibb Company
• Galena Biopharma Inc.
• Gilead Sciences Inc.
• Italfarmaco S.p.A.
• Karus Therapeutics Limited
• Merck & Co. Inc.
• miRagen Therapeutics Inc.
• Nerviano Medical Sciences S.r.l.
• Novartis AG
• PharmaEssentia Corporation

【レポートのキーワード】

多血症

★調査レポート[多血症治療薬の世界市場:市場インサイト、疫学、市場予測]販売に関する免責事項
★調査レポート[多血症治療薬の世界市場:市場インサイト、疫学、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆